A Review of Research Progress on Agathis dammara and Its Application Prospects for Cardiovascular Diseases and Fatty Liver Disease
Journal: 2020/November - Mini-Reviews in Medicinal Chemistry
Abstract:
Cardiovascular diseases and fatty liver disease have become the leading causes of death in modern society. However, currently existing drugs do not solve all issues related to these diseases; thus, it is expected that more potential drugs for clinical use will be developed. Undeniably, natural products have attracted increasing attention. It is of great significance to identify effective active monomer components for drug discovery and disease prevention. As a pure natural product, Agathis dammara (AD) has antioxidant, hypolipidemic, hypoglycemic, antitumor and anti-inflammatory activities. However, at present, there are few reports regarding the effects of AD on chronic inflammatory cardiovascular diseases such as aneurysm, atherosclerosis, myocardial ischemia-reperfusion injury, and cardiac hypertrophy and liver diseases such as fatty liver disease. AD and products derived from it have very broad application prospects for cardiovascular diseases and fatty liver disease.
Keywords: Agathis dammara; anti-inflammatory; antioxidant; application prospects; cardiovascular diseases; fatty liver disease.
Relations:
Diseases
(5)
Conditions
(2)
Similar articles
Articles by the same authors
Discussion board
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.